Erratum: A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease

@article{Choi2015ErratumAP,
  title={Erratum: A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease},
  author={J. Choi and B. Lee and J. M. Ko and Y. B. Sohn and Jin-Sung Lee and Gu-Hwan Kim and S. Heo and June-Young Park and Y. Kim and Ja-Hye Kim and Han-Wook Yoo},
  journal={Journal of Korean Medical Science},
  year={2015},
  volume={30},
  pages={1373 - 1373}
}
  • J. Choi, B. Lee, +8 authors Han-Wook Yoo
  • Published 2015
  • Medicine
  • Journal of Korean Medical Science
  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. pISSN 1011-8934 eISSN 1598-6357 http://dx.doi.org/10.3346/jkms.2015.30.9.1373 • J Korean Med Sci 2015; 30: 1373 CORRESPONDENCE 
    2 Citations

    Topics from this paper

    The road to biosimilars in rare diseases ‐ ongoing lessons from Gaucher disease
    Recent advances and future challenges in Gaucher disease.
    • 6